Literature DB >> 27580788

It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients.

Edoardo Savarino1, Manuele Furnari2, Andrea Ottonello3, Vincenzo Savarino2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27580788     DOI： 10.1038/ajg.2016.290

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  8 in total

1.  Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

Authors:  A Gasbarrini; G R Corazza; G Gasbarrini; M Montalto; M Di Stefano; G Basilisco; A Parodi; P Usai-Satta; P U Satta; P Vernia; C Anania; M Astegiano; G Barbara; L Benini; P Bonazzi; G Capurso; M Certo; A Colecchia; L Cuoco; A Di Sario; D Festi; C Lauritano; E Miceli; G Nardone; F Perri; P Portincasa; R Risicato; M Sorge; A Tursi
Journal:  Aliment Pharmacol Ther       Date:  2009-03-30       Impact factor: 8.171

2.  Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?

Authors:  Amit Gupta; William D Chey
Journal:  Am J Gastroenterol       Date:  2016-03-01       Impact factor: 10.864

3.  Breath Testing for Small Intestinal Bacterial Overgrowth: Should We Bother?

Authors:  Mark Pimentel
Journal:  Am J Gastroenterol       Date:  2016-02-23       Impact factor: 10.864

4.  Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.

Authors:  M Furnari; A Parodi; L Gemignani; E G Giannini; S Marenco; E Savarino; L Assandri; V Fazio; D Bonfanti; S Inferrera; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2010-08-18       Impact factor: 8.171

Review 5.  Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.

Authors:  Brennan M R Spiegel
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-11       Impact factor: 11.382

6.  Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication.

Authors:  Andrea Parodi; Stefania Paolino; Alfredo Greco; Francesco Drago; Carlo Mansi; Alfredo Rebora; Aurora Parodi; Vincenzo Savarino
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

7.  Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.

Authors:  Andrea Parodi; Marta Sessarego; Alfredo Greco; Marco Bazzica; Gilberto Filaci; Maurizio Setti; Edoardo Savarino; Francesco Indiveri; Vincenzo Savarino; Massimo Ghio
Journal:  Am J Gastroenterol       Date:  2008-04-16       Impact factor: 10.864

8.  Positive glucose breath testing is more prevalent in patients with IBS-like symptoms compared with controls of similar age and gender distribution.

Authors:  Andrea Parodi; Pietro Dulbecco; Edoardo Savarino; Edoardo Giovanni Giannini; Giorgia Bodini; Marina Corbo; Luca Isola; Stefano De Conca; Elisa Marabotto; Vincenzo Savarino
Journal:  J Clin Gastroenterol       Date:  2009 Nov-Dec       Impact factor: 3.062
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.